587 related articles for article (PubMed ID: 18154452)
21. Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer.
Gupta A; Singh MS; Singh B
Front Pharmacol; 2024; 15():1380371. PubMed ID: 38766631
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).
Ahmed-Belkacem A; Pozza A; Macalou S; Pérez-Victoria JM; Boumendjel A; Di Pietro A
Anticancer Drugs; 2006 Mar; 17(3):239-43. PubMed ID: 16520651
[TBL] [Abstract][Full Text] [Related]
23. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
24. ATP-binding cassette efflux transporters in human placenta.
Ni Z; Mao Q
Curr Pharm Biotechnol; 2011 Apr; 12(4):674-85. PubMed ID: 21118087
[TBL] [Abstract][Full Text] [Related]
25. Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle.
Haslam IS; El-Chami C; Faruqi H; Shahmalak A; O'Neill CA; Paus R
Br J Dermatol; 2015 Jun; 172(6):1562-1572. PubMed ID: 25418064
[TBL] [Abstract][Full Text] [Related]
26. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
[TBL] [Abstract][Full Text] [Related]
27. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
[TBL] [Abstract][Full Text] [Related]
28. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
29. Characterization of ABC transporters in human skin.
Osman-Ponchet H; Boulai A; Kouidhi M; Sevin K; Alriquet M; Gaborit A; Bertino B; Comby P; Ruty B
Drug Metabol Drug Interact; 2014; 29(2):91-100. PubMed ID: 24558228
[TBL] [Abstract][Full Text] [Related]
30. Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2.
Shafi T; Jabeen I
Curr Cancer Drug Targets; 2017; 17(2):177-190. PubMed ID: 27585695
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
He SM; Li R; Kanwar JR; Zhou SF
Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
[TBL] [Abstract][Full Text] [Related]
32. The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1).
Wiese M; Stefan SM
Med Res Rev; 2019 Nov; 39(6):2031-2081. PubMed ID: 30941807
[TBL] [Abstract][Full Text] [Related]
33. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
34. The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.
Cervenak J; Andrikovics H; Ozvegy-Laczka C; Tordai A; Német K; Váradi A; Sarkadi B
Cancer Lett; 2006 Mar; 234(1):62-72. PubMed ID: 16337740
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).
Gradhand U; Kim RB
Drug Metab Rev; 2008; 40(2):317-54. PubMed ID: 18464048
[TBL] [Abstract][Full Text] [Related]
36. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
38. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH
Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643
[TBL] [Abstract][Full Text] [Related]
39. The role of ATP binding cassette transporters in tissue defense and organ regeneration.
Huls M; Russel FG; Masereeuw R
J Pharmacol Exp Ther; 2009 Jan; 328(1):3-9. PubMed ID: 18791064
[TBL] [Abstract][Full Text] [Related]
40. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]